Network Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report By Product (i-STAT, Accu-Chek Inform II, StatStrip, HemoCue, CareSens Expert Plus, BAROzen H Expert Plus), By Region, And Segment Forecasts, 2021 - 2028

September 2021 | 90 pages | ID: N23DFA98834EEN
Grand View Research, Inc.

Abstracts

This report can be delivered to the clients within Immediate

Network Point-of-Care Glucose Testing Market Growth & Trends

The global network point-of-care glucose testing market size is expected to reach USD 1.6 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 3.9% from 2021 to 2028. Increasing demand for safe and accurate remote patient monitoring options and the need for data-based treatment regimens are major factors driving the market. The integration of advanced technologies including Bluetooth Low Energy (BLE) and Infrared is expected to fuel the market growth in the upcoming years.

Expanding patient base in Asia Pacific and the Middle East and the high demand for advanced diabetes management systems are creating significant growth opportunities in these regions. These regions also include some of the highly preferred destinations for medical tourism. Increasing demand for world-class healthcare services and rising adoption of advanced technology are some of the factors boosting the market growth in these regions.

Network point-of-care glucose meters were extensively used in COVID-19 care. This enabled doctors to remotely observe glucose levels with minimal risk of infection. In addition, a large amount of data is still being used to customize treatment plans for diabetic COVID-19 patients. Preference for telemedicine and trends of home healthcare settings for chronic patients are some of the factors expected to expand the applications of network-based point-of-care devices.

Network Point-of-Care Glucose Testing Market Report Highlights

• Network point-of-care devices were in high demand during the first and second wave of COVID-19 owing to their advantage of remote patient monitoring
• Based on product, the Accu-Chek Inform II segment held the largest revenue share in 2020 and is expected to expand at a lucrative growth rate during the forecast period
• North America held the largest revenue share in 2020 and is predicted to maintain its lead over the forecast period owing to the factors such as the presence of major players and high adoption rate

Contents

CHAPTER 1 METHODOLOGY AND SCOPE

1.1 Market Segmentation & Scope
  1.1.1 Product
  1.1.2 Regional Scope
  1.1.3 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
  1.3.1 Purchased Database
  1.3.2 GVR’s Internal Database
  1.3.3 Secondary Sources
  1.3.4 Primary Research
  1.3.5 Details of Primary Research
    1.3.5.1 Data for primary interviews in North America
    1.3.5.3 Data for Primary Interviews in Europe
    1.3.5.4 Data for Primary Interviews in APAC
    1.3.5.6 Data for Primary Interviews in Latin America
    1.3.5.8 Data for Primary Interviews in MEA
1.4 Information or Data Analysis
  1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
  1.6.1 Commodity Flow Analysis (Model 1)
    1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 Objectives
  1.8.1 Objective 1:
  1.8.2 Objective 2:

CHAPTER 2 EXECUTIVE SUMMARY

2.1 Market Outlook

CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE

3.1 Market Dynamics
  3.1.1 Market Driver Analysis
    3.1.1.1 Introduction of CLIA waived tests
    3.1.1.2 Untapped opportunities in the developing economies
    3.1.1.3 Rising demand for short turnaround time glucose POC testing
    3.1.1.4 Growing focus on diabetes care
  3.1.2 Market Restraint Analysis
    3.1.2.1 Potential interference and calibration issues in glucose meters
    3.1.2.2 Presence of ambiguous regulatory as well as reimbursement framework
3.2 Network Point-of-Care Glucose Testing Market Analysis Tools
  3.2.1 Industry Analysis - Porter’s
  3.2.2 PESTEL Analysis
  3.2.3 Reimbursement Scenario
  3.2.4 Market Share Analysis, By Product, 2020 (%)
  3.2.5 Market Share Analysis, By Region, 2020 (%)
  3.2.6 Pricing Analysis
    3.2.6.1 North America
    3.2.6.2 Europe
    3.2.6.3 Asia Pacific
    3.2.6.4 Latin America
    3.2.6.5 Middle East and Africa

CHAPTER 4 NETWORK POINT-OF-CARE GLUCOSE TESTING: PRODUCT ESTIMATES & TREND ANALYSIS

4.1 Definitions and Scope
4.2 Product Market Share Analysis
4.3 Segment Dashboard
4.4 Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
4.5 i-STAT
  4.5.1 i-STAT Market Estimates And Forecast, 2016 - 2028
4.6 Accu-Chek Inform II
  4.6.1 Accu-Chek Inform II Estimates And Forecast, 2016 - 2028
4.7 StatStrip
  4.7.1 StatStrip Market Estimates And Forecast, 2016 - 2028
4.8 HemoCue
  4.8.1 HemoCue Market Estimates And Forecast, 2016 - 2028
4.9 CareSens Expert Plus
  4.9.1 CareSens Expert Plus Market Estimates And Forecast, 2016 - 2028
4.10 BAROzen H Expert Plus
  4.10.1 BAROzen H Expert Plus Market Estimates And Forecast, 2016 - 2028

CHAPTER 5 NETWORK POINT-OF-CARE GLUCOSE TESTING MARKET: REGIONAL MARKET ANALYSIS, 2016 - 2028 (VALUE) (USD MILLION)

5.1 Regional market share analysis, 2020 & 2028
5.2 North America
  5.2.1 North America Network Point-of-care glucose testing market, 2016 - 2028 (USD Million)
  5.2.2 U.S.
    5.2.2.1 U.S. Network Point-of-care glucose testing market, 2016 - 2028 (USD Million)
  5.2.3 Canada
    5.2.3.1 Canada Network Point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.3 Europe
  5.3.1 Europe Network Point-of-care glucose testing market, 2016 - 2028 (USD Million)
  5.3.2 U.K.
    5.3.2.1 U.K. Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
  5.3.3 Germany
    5.3.3.1 Germany Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
  5.3.4 France
    5.3.4.1 France Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
  5.3.5 Italy
    5.3.5.1 Italy network point-of-care glucose testing market, 2016 - 2028 (USD Million)
  5.3.6 Spain
    5.3.6.1 Spain Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
  5.3.7 Russia
    5.3.7.1 Russia Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.4 Asia Pacific
  5.4.1 Asia Pacific Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
  5.4.2 Japan
    5.4.2.1 Japan Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
  5.4.3 China
    5.4.3.1 China Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
  5.4.4 India
    5.4.4.1 India Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
  5.4.5 Australia
    5.4.5.1 Australia network point-of-care glucose testing market, 2016 - 2028 (USD Million)
  5.4.6 South Korea
    5.4.6.1 South Korea network point-of-care glucose testing market, 2016 - 2028 (USD Million)
  5.4.7 Thailand
    5.4.7.1 Thailand Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.5 Latin America
  5.5.1 Latin America network point-of-care glucose testing market, 2016 - 2028 (USD Million)
  5.5.2 Brazil
    5.5.2.1 Brazil network point-of-care glucose testing market, 2016 - 2028 (USD Million)
  5.5.3 Mexico
    5.5.3.1 Mexico Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
  5.5.4 Argentina
    5.5.4.1 Argentina network point-of-care glucose testing market, 2016 - 2028 (USD Million)
  5.5.5 Colombia
    5.5.5.1 Colombia network point-of-care glucose testing market, 2016 - 2028 (USD Million)
5.6 MEA
  5.6.1 MEA Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
  5.6.2 South Africa
    5.6.2.1 South Africa Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
  5.6.3 Saudi Arabia
    5.6.3.1 Saudi Arabia Network point-of-care glucose testing market, 2016 - 2028 (USD Million)
  5.6.4 UAE
    5.6.4.1 UAE Network point-of-care glucose testing market, 2016 - 2028 (USD Million)

CHAPTER 6 COMPETITIVE LANDSCAPE

6.1 Company profiles
  6.1.1 F. Hoffmann-La Roche Ltd.
    6.1.1.1 Company Overview
    6.1.1.2 Financial performance
    6.1.1.3 Product Benchmarking
  6.1.2 Abbott
    6.1.2.1 Company Overview
    6.1.2.2 Financial performance
    6.1.2.3 Product Benchmarking
    6.1.2.4 Recent Developments
  6.1.3 Nova Biomedical
    6.1.3.1 Company Overview
    6.1.3.2 Product Benchmarking
    6.1.3.3 Recent Developments
  6.1.4 Bayer AG/Ascensia Diabetes Care Holdings AG
    6.1.4.1 Company Overview
    6.1.4.2 Financial Performance
    6.1.4.3 Product Benchmarking
  6.1.5 Danaher
    6.1.5.1 Company Overview
    6.1.5.2 Financial performance
    6.1.5.3 Product Benchmarking
    6.1.5.4 Recent Developments

List Of Tables

LIST OF TABLES

Table 1 Market research process
Table 2 Data triangulation techniques
Table 3 Primary research pattern
Table 4 Primary interviews in North America
Table 5 Primary interviews in Europe
Table 6 Primary interviews in APAC
Table 7 Primary interviews in Latin America
Table 8 Primary interviews in MEA
Table 9 Market research approaches
Table 10 Value-chain-based sizing & forecasting
Table 11 QFD modeling for market share assessment
Table 12 Market formulation & validation
Table 13 Network Point-of-Care Glucose Testing Market: Market Outlook (USD Mn), 2020
Table 14 Shift in POC molecular diagnostic trends
Table 15 Schematic representation of POC testing device connectivity
Table 16 Porter’s five forces analysis
Table 17 SWOT analysis, by factor (political & legal, economic and technological)
Table 18 Network point-of-care glucose testing market: Product movement analysis
Table 19 Network Point-of-care glucose testing market: Product outlook and key takeaways
Table 20 i-STAT market estimates and forecast, 2016 - 2028
Table 21 Accu-Chek Inform II market estimates and forecast, 2016 - 2028
Table 22 StatStrip market estimates and forecast, 2016 - 2028
Table 23 HemoCue market estimates and forecast, 2016 - 2028
Table 24 CareSens Expert Plus market estimates and forecast, 2016 - 2028
Table 25 BAROzen H Expert Plus market estimates and forecast, 2016 - 2028
Table 26 Network global point-of-care glucose testing market: Regional movement analysis
Table 27 North America network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 28 U.S. network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 29 Canada network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 30 Europe network point-of-care) glucose testing market, 2016 - 2028 (USD Million)
Table 31 U.K. network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 32 Germany network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 33 France network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 34 Italy network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 35 Spain network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 36 Russia network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 37 Asia Pacific network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 38 Japan network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 39 China network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 40 India network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 41 Australia network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 42 South Korea network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 43 Thailand network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 44 Latin America network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 45 Brazil network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 46 Mexico network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 47 Argentina network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 48 Colombia network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 49 MEA network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 50 South Africa network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 51 Saudi Arabia network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Table 52 UAE network point-of-care glucose testing market, 2016 - 2028 (USD Million)

List Of Figures

LIST OF FIGURES

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Network Point-of-Care Glucose Testing Market: Market Outlook (USD Mn), 2020
Fig. 14 Shift in POC molecular diagnostic trends
Fig. 15 Schematic representation of POC testing device connectivity
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 Network point-of-care glucose testing market: Product movement analysis
Fig. 19 Network Point-of-care glucose testing market: Product outlook and key takeaways
Fig. 20 i-STAT market estimates and forecast, 2016 - 2028
Fig. 21 Accu-Chek Inform II market estimates and forecast, 2016 - 2028
Fig. 22 StatStrip market estimates and forecast, 2016 - 2028
Fig. 23 HemoCue market estimates and forecast, 2016 - 2028
Fig. 24 CareSens Expert Plus market estimates and forecast, 2016 - 2028
Fig. 25 BAROzen H Expert Plus market estimates and forecast, 2016 - 2028
Fig. 26 Network global point-of-care glucose testing market: Regional movement analysis
Fig. 27 North America network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Fig. 28 U.S. network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Fig. 29 Canada network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Fig. 30 Europe network point-of-care) glucose testing market, 2016 - 2028 (USD Million)
Fig. 31 U.K. network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Fig. 32 Germany network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Fig. 33 France network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Fig. 34 Italy network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Fig. 35 Spain network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Fig. 36 Russia network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Fig. 37 Asia Pacific network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Fig. 38 Japan network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Fig. 39 China network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Fig. 40 India network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Fig. 41 Australia network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Fig. 42 South Korea network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Fig. 43 Thailand network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Fig. 44 Latin America network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Fig. 45 Brazil network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Fig. 46 Mexico network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Fig. 47 Argentina network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Fig. 48 Colombia network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Fig. 49 MEA network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Fig. 50 South Africa network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Fig. 51 Saudi Arabia network point-of-care glucose testing market, 2016 - 2028 (USD Million)
Fig. 52 UAE network point-of-care glucose testing market, 2016 - 2028 (USD Million)